MAIA Biotechnology, Inc. Employee Directory
Biotechnology ResearchIllinois, United States11-50 Employees
MAIA Biotechnology is a Chicago-based biotechnology company focused on developing targeted immunotherapies for cancer. It aims to deliver first-in-class drugs with novel mechanisms that could meaningfully extend patients' lives, through both development and potential commercialization. The company structures its portfolio with drug candidates placed in dedicated R&D-focused subsidiary companies, enabling focused development while sharing core resources to maintain a lean operation. Operating in the biotechnology research industry, MAIA is publicly traded on the NYSE American under the MAIA ticker and manages a portfolio of immunotherapy candidates. In 2026, it presented a poster outlining the methodology and study design for its pivotal THIO-104 Phase 3 program at ASCO in Chicago, reflecting ongoing clinical activity.